An announcement from Autolus Therapeutics Plc (AUTL) is now available.
On March 14, 2024, the Company will share its annual results using an updated corporate presentation during its conference call. This presentation is not considered part of the formal financial filings. Additionally, the Company announced the resignation of Dr. Edgar Braendle, the Chief Development Officer, who will continue as a consultant to facilitate a seamless transition.
See more data about AUTL stock on TipRanks’ Stock Analysis page.
